# Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit

> **NCT06881329** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 61 (actual)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal
- Delayed Cerebral Ischemia
- Cerebral Vasospasm After Subarachnoid Hemorrhage
- Intracranial Aneurysm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06881329
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-20
- **Primary completion:** 2025-01-12
- **Final completion:** 2025-12-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881329, "Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06881329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*